βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism

被引:333
|
作者
Ding, Xunshan [1 ,2 ]
Boney-Montoya, Jamie [2 ]
Owen, Bryn M. [1 ]
Bookout, Angie L. [1 ,3 ]
Coate, Katie Colbert [1 ,4 ]
Mangelsdorf, David J. [1 ,4 ]
Kliewer, Steven A. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
INCREASES ENERGY-EXPENDITURE; ACTIVATED-RECEPTOR-GAMMA; PPAR-ALPHA; INSULIN SENSITIVITY; ADIPOSE-TISSUE; FGF21; MICE; FIBROBLAST-GROWTH-FACTOR-21; EXPRESSION; SYSTEM;
D O I
10.1016/j.cmet.2012.08.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fibroblast growth factor 21 (FGF21) is a fasting-induced hepatokine that has potent pharmacologic effects in mice, which include improving insulin sensitivity and blunting growth. The single-transmembrane protein beta Klotho functions as a coreceptor for FGF21 in vitro. To determine if beta Klotho is required for FGF21 action in vivo, we generated whole-body and adipose tissue-selective beta Klotho-knockout mice. All of the effects of FGF21 on growth and metabolism were lost in whole-body beta Klotho-knockout mice. Selective elimination of beta Klotho in adipose tissue blocked the acute insulin-sensitizing effects of FGF21. Taken together, these data demonstrate that beta Klotho is essential for FGF21 activity and that beta Klotho in adipose tissue contributes to the beneficial metabolic actions of FGF21.
引用
收藏
页码:387 / 393
页数:7
相关论文
共 50 条
  • [31] Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children
    Svenja Kristin Kunert
    Hans Hartmann
    Dieter Haffner
    Maren Leifheit-Nestler
    Journal of Bone and Mineral Metabolism, 2017, 35 : 215 - 226
  • [32] Regulation of fibroblast growth factor-23 signaling by Klotho
    Kurosu, H
    Ogawa, Y
    Miyoshi, M
    Yamamoto, M
    Nandi, A
    Rosenblatt, KP
    Baum, MG
    Schiavi, S
    Hu, CM
    Moe, OW
    Kuro-o, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) : 6120 - 6123
  • [33] Fibroblast growth factor 23 enhances renal klotho abundance
    Takenaka, Tsuneo
    Watanabe, Yusuke
    Inoue, Tsutomu
    Miyazaki, Takashi
    Suzuki, Hiromichi
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2013, 465 (07): : 935 - 943
  • [34] Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding
    Loyd, Christine
    Magrisso, I. Jack
    Haas, Michael
    Balusu, Sowmya
    Krishna, Radha
    Itoh, Nobuyuki
    Sandoval, Darleen A.
    Perez-Tilve, Diego
    Obici, Silvana
    Habegger, Kirk M.
    JOURNAL OF APPLIED PHYSIOLOGY, 2016, 121 (03) : 687 - 698
  • [35] αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats
    de Albuquerque Suassuna, Paulo Giovani
    Cherem, Paula Marocolo
    de Castro, Barbara Bruna
    Maquigussa, Edgar
    Cenedeze, Marco Antonio
    Moraes Lovisi, Julio Cesar
    Custodio, Melani Ribeiro
    Sanders-Pinheiro, Helady
    de Paula, Rogerio Baumgratz
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 245 (01) : 66 - 78
  • [36] Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21) in Vivo
    Fisher, Ffolliott M.
    Estall, Jennifer L.
    Adams, Andrew C.
    Antonellis, Patrick J.
    Bina, Holly A.
    Flier, Jeffrey S.
    Kharitonenkov, Alexei
    Spiegelman, Bruce M.
    Maratos-Flier, Eleftheria
    ENDOCRINOLOGY, 2011, 152 (08) : 2996 - 3004
  • [37] Metabolic actions of fibroblast growth factor 21
    Cuevas-Ramos, Daniel
    Aguilar-Salinas, Carlos A.
    Gomez-Perez, Francisco J.
    CURRENT OPINION IN PEDIATRICS, 2012, 24 (04) : 523 - 529
  • [38] Fibroblast growth factor 21 in metabolic syndrome
    Yang, Ming
    Liu, Chongbin
    Jiang, Na
    Liu, Yan
    Luo, Shilu
    Li, Chenrui
    Zhao, Hao
    Han, Yachun
    Chen, Wei
    Li, Li
    Xiao, Li
    Sun, Lin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [39] Fibroblast Growth Factor 21 in Patients with Acromegaly
    Halupczok-Zyla, Jowita
    Jawiarczyk-Przybylowska, Aleksandra
    Skrzypski, Marek
    Strowski, Mathias Z.
    Bolanowski, Marek
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 649 - 654
  • [40] Fibroblast growth factor 21 in heart failure
    William Tucker
    Bradley Tucker
    Kerry-Anne Rye
    Kwok Leung Ong
    Heart Failure Reviews, 2023, 28 : 261 - 272